Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0100191136
Wed, 30.09.2020
Relief Therapeutics Holdings AG
EQS Group-News: Relief Therapeutics Holdings AG
/ Key word(s): Miscellaneous
NeuroRx and Relief Therapeutics Establish Supply and Distribution Agreements for RLF-100(TM) (aviptadil)
30.09.2020 / 07:00
NeuroRx and Relief Therapeutics Establish Supply and Distribution Agreements for RLF-100(TM) (aviptadil)
Development partners es [ … ]
Mon, 28.09.2020
Relief Therapeutics Holdings AG
EQS Group-News: Relief Therapeutics Holdings AG
/ Key word(s): Capital Increase
Relief Announces Capital Increase from its Final Tranche of the Share Subscription Facility with GEM
28.09.2020 / 07:00
Relief Announces Capital Increase from its Final Tranche of the Share Subscription Facility with GEM
Geneva, Switzerland, Septem [ … ]
Wed, 23.09.2020
Relief Therapeutics Holdings AG
EQS Group-News: Relief Therapeutics Holdings AG
/ Key word(s): Miscellaneous
Relief partner NeuroRx submits request for Emergency Use Authorization for RLF-100(TM) (aviptadil) in the treatment of patients with Critical COVID-19 and Respiratory Failure who have exhausted approved therapy
23.09.2020 / 07:02
Relief partner NeuroRx [ … ]
Mon, 21.09.2020
Relief Therapeutics Holdings AG
EQS Group-News: Relief Therapeutics Holdings AG
/ Key word(s): Agreement
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
21.09.2020 / 07:00
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partn [ … ]
Tue, 15.09.2020
Relief Therapeutics Holdings AG
Relief Reports Half-Year 2020 Results
Geneva, Switzerland, September 15, 2020 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100 (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced its results for the half year [ … ]
Fri, 04.09.2020
Relief Therapeutics Holdings AG
EQS Group-News: Relief Therapeutics Holdings AG
/ Key word(s): Personnel
Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer
04.09.2020 / 07:00
Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer
Geneva, Switzerland, September 04, 2020 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Rel [ … ]
Mon, 31.08.2020
Relief Therapeutics Holdings AG
EQS Group-News: Relief Therapeutics Holdings AG
/ Key word(s): Capital Increase
Relief Announces Successful Up-listing from OTC Pink to OTCQB and Capital Increase from its Share Subscription Facility with GEM
31.08.2020 / 07:00
Relief Announces Successful Up-listing from OTC Pink to OTCQB and Capital Increase from its Share Subs [ … ]